Meixi Hao

448 total citations
15 papers, 363 citations indexed

About

Meixi Hao is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Meixi Hao has authored 15 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Meixi Hao's work include Vitamin D Research Studies (5 papers), Estrogen and related hormone effects (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Meixi Hao is often cited by papers focused on Vitamin D Research Studies (5 papers), Estrogen and related hormone effects (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Meixi Hao collaborates with scholars based in China. Meixi Hao's co-authors include Can Zhang, Caoyun Ju, Lingjing Xue, Weishuo Li, Siyuan Hou, Lulu Zhu, Kaiming Li, Yue Chen, Hongbin Sun and Zhigui Su and has published in prestigious journals such as Nano Letters, ACS Nano and Advanced Drug Delivery Reviews.

In The Last Decade

Meixi Hao

15 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Meixi Hao China	10	139	129	116	104	52	15	363
Armin Ahmadi United States	12	153 1.1×	233 1.8×	120 1.0×	126 1.2×	77 1.5×	23	511
Ninad Kumbhojkar United States	9	132 0.9×	151 1.2×	134 1.2×	79 0.8×	40 0.8×	14	377
Dean Shuailin Chen China	7	79 0.6×	225 1.7×	187 1.6×	62 0.6×	57 1.1×	8	445
Isabella Monia Montagner Italy	12	121 0.9×	186 1.4×	66 0.6×	183 1.8×	86 1.7×	23	484
Tara Lee Costich United States	10	100 0.7×	153 1.2×	34 0.3×	86 0.8×	61 1.2×	17	383
Noah Gorelick United States	10	65 0.5×	181 1.4×	136 1.2×	92 0.9×	155 3.0×	22	472
Jonathan Schupp Germany	9	135 1.0×	130 1.0×	57 0.5×	100 1.0×	61 1.2×	16	336
Stephanie J. Wang United States	7	93 0.7×	167 1.3×	99 0.9×	101 1.0×	53 1.0×	9	343
Daniel S. Bejan United States	9	104 0.7×	217 1.7×	150 1.3×	174 1.7×	97 1.9×	17	448
Mathangi Srinivasan United States	6	155 1.1×	129 1.0×	64 0.6×	61 0.6×	49 0.9×	9	411

Countries citing papers authored by Meixi Hao

Since Specialization

Citations

This map shows the geographic impact of Meixi Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meixi Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meixi Hao more than expected).

Fields of papers citing papers by Meixi Hao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meixi Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meixi Hao. The network helps show where Meixi Hao may publish in the future.

Co-authorship network of co-authors of Meixi Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Meixi Hao. A scholar is included among the top collaborators of Meixi Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meixi Hao. Meixi Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hao, Meixi, Sijia Chen, Xiuqi Li, et al.. (2024). Spatiotemporally Controlled T‐Cell Combination Therapy for Solid Tumor. Advanced Science. 11(25). e2401100–e2401100. 2 indexed citations

Li, Xiuqi, Xinyi Zhang, Lingjing Xue, et al.. (2024). Small-Molecule Therapeutics Achieve Multiple Mechanism-Mediated Sensitizations of Colorectal Cancer to Immune Checkpoint Blockade via Neutrophil Micropharmacies. Nano Letters. 24(45). 14531–14540. 2 indexed citations

Chen, Sijia, Meng Wang, Lingjing Xue, et al.. (2024). Enhancing Glioblastoma Immunotherapy with Integrated Chimeric Antigen Receptor T Cells through the Re-Education of Tumor-Associated Microglia and Macrophages. ACS Nano. 18(17). 11165–11182. 18 indexed citations

Hao, Meixi, Lulu Zhu, Siyuan Hou, et al.. (2023). Sensitizing Tumors to Immune Checkpoint Blockage via STING Agonists Delivered by Tumor-Penetrating Neutrophil Cytopharmaceuticals. ACS Nano. 17(2). 1663–1680. 58 indexed citations

Li, Kaiming, Yue Chen, Sijia Chen, et al.. (2022). Real-time detection of T cell activation by visualizing TCR nanoclusters with a cholesterol derived aggregation-induced emission probe. European Journal of Medicinal Chemistry. 247. 115073–115073. 4 indexed citations

Li, Weishuo, Meixi Hao, Yujiao Wang, et al.. (2022). An EPR-Independent extravasation Strategy: Deformable leukocytes as vehicles for improved solid tumor therapy. Advanced Drug Delivery Reviews. 187. 114380–114380. 11 indexed citations

Yu, Tao, Ding Qu, Lingjing Xue, et al.. (2021). Modular synthesis of amphiphilic chitosan derivatives based on copper-free click reaction for drug delivery. International Journal of Pharmaceutics. 605. 120798–120798. 13 indexed citations

Hao, Meixi, Siyuan Hou, Weishuo Li, et al.. (2020). Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy. Science Translational Medicine. 12(571). 142 indexed citations

Li, Weishuo, Zhigui Su, Meixi Hao, Caoyun Ju, & Can Zhang. (2020). Cytopharmaceuticals: An emerging paradigm for drug delivery. Journal of Controlled Release. 328. 313–324. 41 indexed citations

10.

Wang, Cong, Tong Yu, Yanyi Li, et al.. (2020). Novel Nonsecosteroidal Vitamin D Receptor Modulator Combined with Gemcitabine Enhances Pancreatic Cancer Therapy through Remodeling of the Tumor Microenvironment. Journal of Medicinal Chemistry. 64(1). 629–643. 21 indexed citations

11.

Wang, Cong, Xiaolin Han, Bin Wang, et al.. (2018). Sulfonyl-containing phenyl-pyrrolyl pentane analogues: Novel non-secosteroidal vitamin D receptor modulators with favorable physicochemical properties, pharmacokinetic properties and anti-tumor activity. European Journal of Medicinal Chemistry. 157. 1174–1191. 9 indexed citations

12.

Hao, Meixi, Siyuan Hou, Lingjing Xue, et al.. (2018). Further Developments of the Phenyl-Pyrrolyl Pentane Series of Nonsteroidal Vitamin D Receptor Modulators as Anticancer Agents. Journal of Medicinal Chemistry. 61(7). 3059–3075. 15 indexed citations

13.

Wang, Bin, Meixi Hao, & Can Zhang. (2017). Design, synthesis and biological evaluation of nonsecosteroidal vitamin D3 receptor ligands as anti-tumor agents. Bioorganic & Medicinal Chemistry Letters. 27(6). 1428–1436. 8 indexed citations

14.

Wang, Tingfang, Xiaofei Liu, Meixi Hao, et al.. (2016). Design, synthesis and evaluation of pyrrolo[2,3-d]pyrimidine-phenylamide hybrids as potent Janus kinase 2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(12). 2936–2941. 11 indexed citations

15.

Hao, Meixi, et al.. (2015). Novel nonsecosteroidal VDR ligands with phenyl-pyrrolyl pentane skeleton for cancer therapy. European Journal of Medicinal Chemistry. 107. 48–62. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact